Embryo News and Research

RSS

New massive sequencing platform implemented for double factor preimplantation genetic testing

A research team from the Universitat Autònoma de Barcelona, in collaboration with the Blood and Tissue Bank of Catalonia, has managed to implement a massive sequencing platform for Preimplantation Genetic Testing for the first time in history.

5 Dec 2018

Successful delivery after womb transplant

A Brazilian woman became the first woman to successfully deliver a baby after having received a womb transplant from a dead donor.

4 Dec 2018

Selective survival of embryos under adverse conditions may explain health problems later in life

An international team led by researchers of the Leiden University Medical Center and Lund University in Sweden propose that selection of random epigenetic differences causes particular embryos to survive under adverse conditions in the womb.

4 Dec 2018

New project explores whether skin wounds can heal without leaving scars

Can skin wounds heal without leaving scars? That's the question being explored in a project entitled ScarLessWorld headed by Dr. Yuval Rinkevich, research group leader at Helmholtz Zentrum München.

3 Dec 2018

Controversial gene editing of embryos stopped by the Chinese authorities

The Chinese government has stopped the gene editing works of Professor He Jiankui calling it unlawful and unethical. Notably Professor Jiankui had recently claimed to have produced the world’s first pair of twins who have their genetic codes edited so that they would never be infected with HIV.

29 Nov 2018

Scientists create mini-placenta's to study early stages of pregnancy

Researchers at the University of Cambridge have used organoid culture techniques to create a cellular model of the early stages of the placenta.

29 Nov 2018

“Placental organoids” could be the future of pregnancy and conception research say researchers

Researchers have successfully managed to develop “mini placentas” or placenta organoids in the laboratories that could transform research of pregnancy, conception, stillbirth, miscarriages and pregnancy diseases and disorders.

29 Nov 2018

Two types of cellular asymmetry govern shaping of cells into sheets and tubes

Scientists have developed a mathematical model showing that two types of cellular asymmetry, or 'polarity', govern the shaping of cells into sheets and tubes, according to an article in eLife.

28 Nov 2018

Researchers attempt to create world's first genetically edited babies

The researchers have used CRISPR to edit the genes of IVF embryos in a controversial attempt to create offspring that are resistant to disease.

26 Nov 2018

FDA approves new treatment for AML patients

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75 years of age or older or who have other chronic health conditions or diseases (comorbidities) that may preclude the use of intensive chemotherapy.

22 Nov 2018

Scientists identify three genes responsible for recurrent molar pregnancies

A team of scientists at the Research Institute of the McGill University Health Centre and McGill University have identified three genes responsible for recurrent molar pregnancies, a rare complication that occurs when a non-viable pregnancy with no embryo implants in the uterus.

20 Nov 2018

Participation project calls for relaxing research ban on germline interventions

Are genetic defects allowed to be repaired by intervening with sperm or egg cells, or even human embryos? Thanks to genetic scissors such as CRISPR/Cas, such interventions in the germline could soon become a medical reality.

19 Nov 2018

Using light to control crucial step in embryonic development

In optogenetics, researchers use light to control protein activity. This technique allows them to alter the shape of embryonic tissue and to inhibit the development of abnormalities.

16 Nov 2018

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus Pharmaceuticals announced today the immediate availability in the United States for Arsenic Trioxide Injection. Nexus Pharmaceuticals' Arsenic Trioxide Injection is available as 10 mg per 10 mL vial for injection.

16 Nov 2018

Determining how hearts develop to better understand congenital heart defects

To understand cardiovascular failures, the leading cause of birth defect-related deaths in infants, UH professor of biomedical engineering Kirill Larin is teaming up with Baylor College of Medicine professor of cellular and molecular physiology Irina Larina on a chicken and egg hunt.

14 Nov 2018

Researchers discover two proteins essential for development of skeletal muscle

All vertebrates need muscles to function; they are the most abundant tissue in the human body and are integral to movement.

12 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Researchers take first step in bioengineering human uterus to treat endometrial diseases

Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.

1 Nov 2018

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Bristol-Myers Squibb Company today announced four-year data from the Phase 3 CheckMate -067 clinical trial - the longest follow-up to date - which continues to demonstrate durable, long-term survival benefits with the first-line combination of Opdivo (nivolumab) and Yervoy (ipilimumab), versus Yervoy alone, in patients with advanced melanoma.

22 Oct 2018

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.

22 Oct 2018

Embryo News and Research

New massive sequencing platform implemented for double factor preimplantation genetic testing

Successful delivery after womb transplant

Selective survival of embryos under adverse conditions may explain health problems later in life

New project explores whether skin wounds can heal without leaving scars

Controversial gene editing of embryos stopped by the Chinese authorities

Scientists create mini-placenta's to study early stages of pregnancy

“Placental organoids” could be the future of pregnancy and conception research say researchers

Two types of cellular asymmetry govern shaping of cells into sheets and tubes

Researchers attempt to create world's first genetically edited babies

FDA approves new treatment for AML patients

Scientists identify three genes responsible for recurrent molar pregnancies

Participation project calls for relaxing research ban on germline interventions

Using light to control crucial step in embryonic development

Nexus announces availability of Arsenic Trioxide Injection in the US

Determining how hearts develop to better understand congenital heart defects

Researchers discover two proteins essential for development of skeletal muscle

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Researchers take first step in bioengineering human uterus to treat endometrial diseases

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News